Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingyi Bi

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Plos One|March 25, 2024
HMGR and CHS gene cloning, characterizations and tissue-specific expressions in Polygala tenuifolia WilldYang Liu, Xiaofang Ma, Fuying Mao, et al.
Acta Haematologica|April 13, 2025
Tucidinostat Combined with Bortezomib, Liposomal Doxorubicin, and Dexamethasone in Multiple Myeloma TreatmentJingyi Bi, Xuelin Dou, Ruqi Liang, et al.
Leukemia & Lymphoma|October 15, 2025
Profound dFLC decrease after one cycle predicts superior outcome in patients with AL amyloidosisYang Liu, Jingyi Bi, Xuelin Dou, et al.
Molecular Therapy. Nucleic Acids|May 11, 2026
ClinASO: An open-source platform for rapid drug discovery of gapmer antisense oligonucleotidesShunkai Chen, Hao Liu, Dezi Cong, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Plos One|March 25, 2024
HMGR and CHS gene cloning, characterizations and tissue-specific expressions in Polygala tenuifolia WilldYang Liu, Xiaofang Ma, Fuying Mao, et al.
Acta Haematologica|April 13, 2025
Tucidinostat Combined with Bortezomib, Liposomal Doxorubicin, and Dexamethasone in Multiple Myeloma TreatmentJingyi Bi, Xuelin Dou, Ruqi Liang, et al.
Leukemia & Lymphoma|October 15, 2025
Profound dFLC decrease after one cycle predicts superior outcome in patients with AL amyloidosisYang Liu, Jingyi Bi, Xuelin Dou, et al.
Molecular Therapy. Nucleic Acids|May 11, 2026
ClinASO: An open-source platform for rapid drug discovery of gapmer antisense oligonucleotidesShunkai Chen, Hao Liu, Dezi Cong, et al.
Pageof 2